Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
Volunteers Sought for Scholarship Review Task Force
Ready to make a meaningful impact? Join us as a volunteer for the 2025 Scholarship Review Task Force and help shape the future of tomorrow’s…
Dizziness and Neck Pain: A Perspective on Cervicogenic Dizziness
Cervicogenic dizziness is a somewhat controversial topic, as this condition is often considered a diagnosis of exclusion without a specific objective standardized test across health-care…
Audiologists Advocate for Fair Use of “Doctor” Title in Florida
This week, the American Academy of Audiology, in collaboration with the Florida Academy of Audiology (FLAA), voiced concerns about House Bill (HB) 1341—legislation that would…